Pacira BioSciences, Inc.

Stock Chart, Company Information, and Scan Results

$22.55(as of Jul 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Pacira BioSciences, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$22.55
Ticker SymbolPCRX
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees788
CountyUSA
Market Cap$1,044.2M
EBIDTA171.8M
10-Day Moving Average22.37
P/E Ratio-10.11
20-Day Moving Average22.85
Forward P/E Ratio7.80
50-Day Moving Average24.33
Earnings per Share-2.24
200-Day Moving Average22.35
Profit Margin2.85%
RSI43.85
Shares Outstanding46.3M
ATR0.83
52-Week High27.64
Volume767,971
52-Week Low11.16
Most Recent Support Level21.26
Book Value798.5M
Most Recent Resistance Level22.95
P/B Ratio1.31
Upper Keltner24.72
P/S Ratio1.49
Lower Keltner20.97
Debt-to-Equity Ratio24.72
Next Earnings Date08/05/2025
Cash Surplus-31.1M
Next Ex-Dividend DateUnknown

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. The company has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Pacira BioSciences, Inc. In Our Stock Scanner

As of Jul 28, 2025
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.